Filsuvez® (birch triterpenes) – New orphan drug approval
December 19, 2023 - Chiesi Global Rare Diseases announced the FDA approval of Filsuvez (birch triterpenes), for the treatment of wounds associated with dystrophic and junctional epidermolysis bullosa (EB) in adult and pediatric patients 6 months of age and older.
Top